Skip to main content
. 2024 Dec 15;16(12):4636–4649. doi: 10.4251/wjgo.v16.i12.4636

Table 1.

Demographics and clinical characteristics of patients, n (%)

Variables
Number of patients
Age
≥ 75 and < 80 70 (50.4)
≥ 80 69 (49.6)
Sex
Female 39 (28.1)
Male 100 (72.9)
Marital status
Married 133 (95.7)
Unmarried 6 (4.3)
Smoke
No 84 (60.4)
Yes 55 (39.6)
Drink
No 102 (73.4)
Yes 37 (26.6)
C stage
I-II 24 (17.3)
III-IVa 93 (66.9)
IVb 22 (15.8)
T stage
T1-T2 22 (15.8)
T3-T4 117 (84.2)
N stage
Negative 22 (15.8)
Positive 117 (84.2)
M stage
M0 117 (84.2)
M1 22 (15.8)
Tumor length
< 6 90 (64.7)
≥ 6 49 (35.3)
Tumor location
Upper thoracic 34 (24.5)
Middle thoracic 62 (44.6)
Lower thoracic 43 (30.9)
ECOG
0-1 133 (95.7)
2 6 (4.3)
CCI
0 62 (44.6)
≥ 1 77 (55.4)
NRS2002
< 3 66 (47.5)
≥ 3 73 (52.5)
BMI
< 18.5 32 (23.0)
≥ 18.5 107 (77.0)
Weight loss
< 10% 128 (92.1)
≥ 10% 11 (7.9)
Radiation dose
< 60 57 (41.0)
≥ 60 82 (59.0)
Chemotherapy
No 36 (25.9)
Yes 103 (74.1)

BMI: Body mass index; ECOG: Eastern Cooperative Oncology Group; CCI: Charlson comorbidity index; NRS2002: Nutritional risk screening 2002.